SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer

Guangyao Li; Qijiao Li; Miaomiao Ping; Ziying Jiao; Xingxing Wang; Juan Cheng; Jizheng Guo; Ya Cheng

doi:doi:10.18632/aging.205850

← Back

Research Paper Volume 16, Issue 10 pp 8944—8964

SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer

Figure 7. The expression of SLAMF8 in TME based on IMMUcan SingleCell RNAseq database. (A) The distribution of SLAMF8 expression in various datasets downloaded from IMMUcan SingleCell RNAseq database. (B, C) The expression of SLAMF8 in various TME cells in NSCLC_UNB_10x_EMTAB6149 and LUAD_MYE_MRS_GSE97168 datasets.